Search research articles
Contact Us
Filters
Showing results (71-80 of 96) with videos related to
Page
of 10
Sort By:
The Journal of Clinical Investigation
|
March 4, 2010
Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
Mari Tanaka, Misako Asada, Atsuko Y Higashi, et al.
Science Translational Medicine
|
November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification
Devaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 31, 2023
Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice
Rene C Adam, Dwaine S Pryce, Joseph S Lee, et al.
Blood
|
August 21, 2014
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts
Maria Krevvata, Barbara C Silva, John S Manavalan, et al.
The Journal of Clinical Investigation
|
May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Senem Aykul, Lily Huang, Lili Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor
Keith D Anderson, Li Pan, Xiao-man Yang, et al.
Elife
|
June 10, 2020
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
Senem Aykul, Richard A Corpina, Erich J Goebel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies
Andrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Nature Medicine
|
December 17, 2002
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Aris N Economides, Laura Rocco Carpenter, John S Rudge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2024
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
Richard Keen, Kathryn M Dahir, Jennifer McGinniss, et al.
Page
of 10
Search research articles
Search
Showing results (71-80 of 96) with videos related to
Sort By:
Page
of 10
The Journal of Clinical Investigation
|
March 4, 2010
Loss of the BMP antagonist USAG-1 ameliorates disease in a mouse model of the progressive hereditary kidney disease Alport syndrome
Mari Tanaka, Misako Asada, Atsuko Y Higashi, et al.
Science Translational Medicine
|
November 25, 2016
Two tissue-resident progenitor lineages drive distinct phenotypes of heterotopic ossification
Devaveena Dey, Jana Bagarova, Sarah J Hatsell, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 31, 2023
Activin E-ACVR1C cross talk controls energy storage via suppression of adipose lipolysis in mice
Rene C Adam, Dwaine S Pryce, Joseph S Lee, et al.
Blood
|
August 21, 2014
Inhibition of leukemia cell engraftment and disease progression in mice by osteoblasts
Maria Krevvata, Barbara C Silva, John S Manavalan, et al.
The Journal of Clinical Investigation
|
May 5, 2022
Anti-ACVR1 antibodies exacerbate heterotopic ossification in fibrodysplasia ossificans progressiva (FOP) by activating FOP-mutant ACVR1
Senem Aykul, Lily Huang, Lili Wang, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
February 2, 2011
Angiogenic sprouting into neural tissue requires Gpr124, an orphan G protein-coupled receptor
Keith D Anderson, Li Pan, Xiao-man Yang, et al.
Elife
|
June 10, 2020
Activin A forms a non-signaling complex with ACVR1 and type II Activin/BMP receptors via its finger 2 tip loop
Senem Aykul, Richard A Corpina, Erich J Goebel, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy
|
August 17, 2021
Cell type-selective targeted delivery of a recombinant lysosomal enzyme for enzyme therapies
Andrew D Baik, Philip Calafati, Xiaoli Zhang, et al.
Nature Medicine
|
December 17, 2002
Cytokine traps: multi-component, high-affinity blockers of cytokine action
Aris N Economides, Laura Rocco Carpenter, John S Rudge, et al.
Journal of Bone and Mineral Research : the Official Journal of the American Society for Bone and Mineral Research
|
August 31, 2024
Characterization of flare-ups and impact of garetosmab in adults with fibrodysplasia ossificans progressiva: a post hoc analysis of the randomized, double-blind, placebo-controlled LUMINA-1 trial
Richard Keen, Kathryn M Dahir, Jennifer McGinniss, et al.
Page
of 10